Previous studies identified the importance of lipopolysaccharide (LPS) engagement of TLR4 in the clearance of Pa infections [21], and thus we hypothesized that the use of a TLR4 agonist would enhance an antibody response specific to CoaB. The gene discussed is PPCS; the disease is infection.